Immatics (IMTX) Change in Receivables (2019 - 2025)
Immatics (IMTX) reported Change in Receivables of -$3.4 million for Q4 2025, down 8.71% on a YoY basis from -$3.7 million in Q4 2024, and down 133.62% sequentially from -$1.4 million in Q3 2025.
Immatics (IMTX) Change in Receivables (2019 - 2025) Analysis & Trends
Immatics (IMTX) has 7 years of Change in Receivables data on file, last reported at -$3.4 million in Q4 2025.
- For the quarter ending Q4 2025, Change in Receivables fell 8.71% year-over-year to -$3.4 million; the trailing twelve-month figure through Dec 2025 stood at -$433406.6 (up 76.66% YoY), and the FY2025 full-year result was -$273414.3, up 85.68% from the prior year.
- Change in Receivables slipped to -$3.4 million in Q4 2025, from -$1.4 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $4.1 million in Q2 2025 to a low of -$3.8 million in Q4 2023.
- A 5-year average of -$263618.7 and a median of -$131326.2 in 2024 frame the typical range for Change in Receivables.
- Peak annual rise in Change in Receivables reached 1479.64% in 2023, while the deepest fall reached 13576.12% in 2023.
- Tracing IMTX's Change in Receivables over 5 years: stood at $50334.7 in 2021, then tumbled by 43.25% to $28566.9 in 2022, then tumbled by 13576.12% to -$3.8 million in 2023, then rose by 19.34% to -$3.1 million in 2024, then decreased by 8.71% to -$3.4 million in 2025.
- Business Quant data shows IMTX's Change in Receivables at -$3.4 million in Q4 2025, -$1.4 million in Q3 2025, and $4.1 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 75.30 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.84 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Immatics | 1.14 Bn | 1.14 Bn | - | -3.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.38 Mn |
| Dec 31, 2025 | -3.38 Mn |
| Sep 30, 2025 | -1.44 Mn |
| Sep 30, 2025 | -1.44 Mn |
| Jun 30, 2025 | 4.12 Mn |
| Jun 30, 2025 | 4.12 Mn |
| Mar 31, 2025 | 270,334.30 |
| Mar 31, 2025 | 270,334.30 |
| Dec 31, 2024 | -3.11 Mn |
| Dec 31, 2024 | -3.11 Mn |
| Sep 30, 2024 | -154,848.95 |
| Sep 30, 2024 | -154,848.95 |
| Jun 30, 2024 | -1.11 Mn |
| Jun 30, 2024 | -1.11 Mn |
| Mar 31, 2024 | 2.51 Mn |
| Mar 31, 2024 | 2.51 Mn |
| Dec 31, 2023 | -3.85 Mn |
| Dec 31, 2023 | -3.85 Mn |
| Sep 30, 2023 | -201,389.24 |
| Sep 30, 2023 | -201,389.24 |